IL1B and type 2 diabetes mellitus: IL-1β is also a prominent pro-inflammatory cytokine whose aberrant expression and regulation drives disease progression in different chronic inflammatory conditions, such as type 2 diabetes [21], and chronic inflammation involving skin and bone [22].